PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-10-28

Date Title Company
28-Oct-2019 MorphoSys AG: MOR106 Clinical Development in Atopic Dermatitis Stopped (news with additional features) MorphoSys AG
28-Oct-2019 MorphoSys AG: Ad hoc: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility MorphoSys AG
28-Oct-2019 Synthetic Biologics to Report 2019 Third Quarter Operational Highlights and Financial Results on November 4, 2019 Synthetic Biologics, Inc.
28-Oct-2019 Kroger Health Pharmacists Now Prescribing Hormonal Contraceptives in Several Markets Kroger Health
28-Oct-2019 European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma EMD Serono
28-Oct-2019 European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma Merck
28-Oct-2019 Amen Clinics to Support and Sponsor Wellness on the Front Line(TM) 2019 Public Safety Peer Support Association (PSPSA) Conference Amen Clinics, Inc.
28-Oct-2019 Prelude Therapeutics expands in Delaware; Adding biotech jobs in cancer drug discovery research Delaware Prosperity Partnership
28-Oct-2019 SP Acquires Spain Based i-Dositecno SP Industries, Inc.
28-Oct-2019 Sterling Pharma Solutions invests $1.5m into US facility expansion Sterling Pharma Solutions
28-Oct-2019 Lonza to Host New Webinar – “Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success” Lonza
28-Oct-2019 ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist and CD73 Inhibitor Programs at AACR-NCI-EORTC Annual Conference ORIC Pharmaceuticals
28-Oct-2019 Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis Arena Pharmaceuticals, Inc.
28-Oct-2019 VistaGen Therapeutics Expands European Patent Protection for AV-101 for Treatment of Depression and Dyskinesia associated with Levodopa Therapy for Parkinson's Disease VistaGen Therapeutics
28-Oct-2019 Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain Heron Therapeutics, Inc.
28-Oct-2019 Actinium Announces Positive Interim Results from Iomab-B Pivotal Phase 3 SIERRA Trial at 50% of Total Patient Enrollment Actinium Pharmaceuticals, Inc.
28-Oct-2019 CDMO to invest over €3m in GMP facility expansion Micro-Sphere
28-Oct-2019 BioMed X Completes Alzheimer’s Disease Research Project B3C newswire
28-Oct-2019 Hill Dickinson health team grows with new partner hire Hill Dickinson
28-Oct-2019 Allergy Rhinitis Drug Market to Rise as a Trendsetter in Technology and Development 2029 | GlaxoSmithKline, Sanofi, ALK-Abello Wired Release